Modern mass spectrometry developments hold significant potential for the discovery and sensitive detection of innovative (sets of) biomarkers which will allow rapid and accurate diagnosis of multiple disorders simultaneously in a single patient’s small-volume sample.

ProteoFormiX is running a mass spectrometry-based top-down proteomics technology platform to identify such disease-associated proteoforms (e.g., peptides) in clinically sampled human body fluids and tissues.

Focus area
Platform / research tool